Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$21.81 USD
+0.27 (1.25%)
Updated May 30, 2024 04:00 PM ET
After-Market: $21.91 +0.10 (0.46%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Brokerage Reports
Silence Therapeutics PLC Sponsored ADR [SLN]
Reports for Purchase
Showing records 21 - 28 ( 28 total )
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
R&D Day Event Highlights Lead RNAi Programs, Broad Pipeline Expansion Underway
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
1H21 results; Lead Programs SLN360 and SLN124, Partnered Programs Progressing; Announces October R&D Day
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Reports Positive Phase 1 Data in SLN124 Program; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
First-in-Human Top-Line Data on Key Assets SLN124 and SLN360 on Track for 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Biotech Should Keep the Wind at its Back in 2021; Top Healthcare Picks
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Emerging Leader in Lp(a) Lowering Race; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Impressive Progress on Multiple Fronts
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department